Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Human immune system may play key role in shaping the microbiome composition

The gut is an unusually noisy place, where hundreds of species of bacteria live alongside whatever microbes happen to have hitched a ride in on your lunch.

30 Oct 2020

Penn State and Stanford University collaborate to develop two-hour sepsis test

One in three people who die in U.S. hospitals have sepsis, the body's extreme response to infection that can lead to multiple organ failure. Diagnosis can take up to five days, but death may take only hours from the initial onset of sepsis.

30 Oct 2020

COVID-19 patients at risk of fatal co-infection during ICU stays

Researchers in the UK have conducted a study showing that a high proportion of patients admitted to intensive care units (ICU) with coronavirus disease 2019 (COVID-19) acquire a secondary bacterial co-infection during their hospital stay.

29 Oct 2020

Researchers use genomic tools and supercomputers to study the infant gut microbiome

Since 2017, University of Alabama at Birmingham researchers Casey Morrow, Ph.D., and Hyunmin Koo, Ph.D., have used powerful genomic tools and supercomputers that analyze massive amounts of genetic data to identify individual strains within single species of the gut microbiome.

29 Oct 2020

Scientists use experimental approach to identify genes and interactions

A phage is a virus that invades a bacterial cell. While harmless to human cells, phages are potentially deadly to bacteria since many phages enter a cell in order to hijack its machinery in order to reproduce itself, thus destroying the cell.

28 Oct 2020

Specific genes of infant gut bacterium determine its symbiotic function in the infant's gut

While an infant's genes distinguish her from other newborns, a new peer-reviewed study reports that specific genes of a particular infant gut bacterium determine its symbiotic function in the infant's gut.

28 Oct 2020

Antibiotic use patterns and patient transfers in hospitals may drive the emergence of drug resistance

Understanding the role of antibiotic use patterns and patient transfers in the emergence of drug-resistant microbes is essential to crafting effective prevention strategies, suggests a study published today in eLife.

27 Oct 2020

Scientists use new approach to chart the spread of drug-resistant hospital bacteria

Scientists have used genome sequencing to reveal the extent to which a drug-resistant gastrointestinal bacterium can spread within a hospital, highlighting the challenge hospitals face in controlling infections.

27 Oct 2020

COVID-19 antibiotic risk factors

Now, a team of researchers at the University of Rochester Medical Center aimed to determine antibiotic prescribing rates and risk factors for antibiotic prescribing in hospitalized patients. They found that almost one-third of patients received more than one course of antibiotics.

27 Oct 2020

New inhibitor of SARS-CoV-2 RNA translation

As the search for effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors continues, a recent study by Yale University School of Medicine researchers published on the preprint server bioRxiv in October 2020 reports the inhibitory effect of the drug merofloxacin on frameshifting during SARS-CoV-2 replication.

26 Oct 2020

Santen joins forces with ophthalmologists in the fight against antibiotic resistance

Santen is delighted to announce the launch of the Re-SOLVE Antibiotic Resistance, which aims to lead the way in the fight against antibiotic resistance.

22 Oct 2020

Scientists develop antibacterial nano-coatings based on boron nitride

NUST MISIS material scientists have presented antibacterial nano-coatings based on boron nitride, which are highly effective against microbial pathogens (up to 99.99%).

20 Oct 2020

Researchers describe how to assess if an antibiotic has a new mechanism of action

The fight against bacterial infections, especially those caused by resistant pathogens, is in full swing with the search for new antibiotic agents.

19 Oct 2020

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

Researchers aim to identify disease tolerance mechanisms in sepsis patients

Sepsis is estimated to cause 11 million deaths every year in the world. Its treatment is based on the use of antibiotics and organ support measures, but many times it fails due to unsuccessful attempts at modulating the immune response.

16 Oct 2020

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

Scientists engineer powerful novel anti-microbial molecules from wasp venom

Now, a team of scientists in the Perelman School of Medicine at the University of Pennsylvania has engineered potent novel anti-microbial molecules from toxic proteins found in wasp venom. The researchers believe that the discovery holds promise in fighting the increasing number of antibiotic-resistant bacteria, that cause serious illness.

15 Oct 2020

Study shows how HGT can bend the rules of evolution

In a world first Monash University scientists have discovered that HGT can bend the rules of evolution. The discovery is outlined in a study published today in PNAS, which was led by ARC Future Fellow Dr Mike McDonald and PhD candidate Laura Woods, both from the Monash University School of Biological Sciences.

15 Oct 2020

SHEA releases updated guidance for healthcare workers with HIV, hepatitis

In light of the low rate of transmission and advances in treatments for hepatitis B, hepatitis C, and HIV, the Society for Healthcare Epidemiology of America today released updated guidance for healthcare personnel living with these bloodborne pathogens based on the latest available science.

14 Oct 2020

Are antibiotics being over prescribed in COVID-19?

A new study published on the preprint server medRxiv in October 2020 shows that the baseline levels of inflammatory markers and C-reactive protein (CRP) in relation to antibiotic administration can rule out bacterial co-infections and help reduce the unnecessary use of antibiotics.

13 Oct 2020

Antibiotic News and Research

Further Reading

Human immune system may play key role in shaping the microbiome composition

Penn State and Stanford University collaborate to develop two-hour sepsis test

COVID-19 patients at risk of fatal co-infection during ICU stays

Researchers use genomic tools and supercomputers to study the infant gut microbiome

Scientists use experimental approach to identify genes and interactions

Specific genes of infant gut bacterium determine its symbiotic function in the infant's gut

Antibiotic use patterns and patient transfers in hospitals may drive the emergence of drug resistance

Scientists use new approach to chart the spread of drug-resistant hospital bacteria

COVID-19 antibiotic risk factors

New inhibitor of SARS-CoV-2 RNA translation

Santen joins forces with ophthalmologists in the fight against antibiotic resistance

Scientists develop antibacterial nano-coatings based on boron nitride

Researchers describe how to assess if an antibiotic has a new mechanism of action

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

Researchers aim to identify disease tolerance mechanisms in sepsis patients

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

Scientists engineer powerful novel anti-microbial molecules from wasp venom

Study shows how HGT can bend the rules of evolution

SHEA releases updated guidance for healthcare workers with HIV, hepatitis

Are antibiotics being over prescribed in COVID-19?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News